EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer

Zhen Ye, Jingru Yang, Hanming Jiang, Xianquan Zhan

Frontiers in Endocrinology · 19.09.2023 · 14

DOI: 10.3389/fendo.2023.1220108 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Endocrinology, online erschienen am 19.09.2023. Verfasst von Zhen Ye und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Science and Technology Innovation Center, Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong Fir…. Hauptthemen laut MEDLINE: Proteasome Endopeptidase Complex, Lung Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The malignant lung cancer has a high morbidity rate and very poor 5-year survival rate. About 80% - 90% of protein degradation in human cells is occurred through the ubiquitination enzyme pathway. Ubiquitin ligase (E3) with high specificity plays a crucial role in the ubiquitination process of the target protein, which usually occurs at a lysine residue in a substrate protein. Different ubiquitination forms have different effects on the target proteins. Multiple short chains of ubiquitination residues modify substrate proteins, which are favorable signals for protein degradation. The dynamic balance adapted to physiological needs between ubiquitination and deubiquitination of intracellular proteins is beneficial to the health of the organism. Ubiquitination of proteins has an impact on many biological pathways, and imbalances in these pathways lead to diseases including lung cancer. Ubiquitination of tumor suppressor protein factors or deubiquitination of tumor carcinogen protein factors often lead to the progression of lung cancer. Ubiquitin proteasome system (UPS) is a treasure house for research and development of new cancer drugs for lung cancer, especially targeting proteasome and E3s. The ubiquitination and degradation of oncogene proteins with precise targeting may provide a bright prospect for drug development in lung cancer; Especially proteolytic targeted chimerism (PROTAC)-induced protein degradation technology will offer a new strategy in the discovery and development of new drugs for lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proteasome Endopeptidase ComplexLung NeoplasmsHumansUbiquitinationUbiquitinProteinsCell Transformation, NeoplasticDrug Discovery

Stichwörter der Autor:innen

PROTACsTargeted drug discoverydeubiquitinationlung cancerubiquitin-proteasome systemubiquitinationubiquitination ligase

Substanzen

Proteasome Endopeptidase ComplexUbiquitinProteins

Autor:innen und Institutionen

  • Medical Science and Technology Innovation Center, Shandong Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, S…
  • School of Clinical and Basic Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.

Zitieren

APA

Ye, Z., Yang, J., Jiang, H., & Zhan, X. (2023). The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer. Frontiers in Endocrinology, 14. https://doi.org/10.3389/fendo.2023.1220108

Vancouver

Ye Z, Yang J, Jiang H, Zhan X. The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer. Frontiers in Endocrinology. 2023;14. doi:10.3389/fendo.2023.1220108

BibTeX
@article{Ye2023,
  author = {Ye, Zhen and Yang, Jingru and Jiang, Hanming and Zhan, Xianquan},
  title = {The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer},
  journal = {Frontiers in Endocrinology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fendo.2023.1220108}
}
Kostenlos starten →